Associations between visceral adiposity index and incident nephropathy outcomes in diabetic patients: Insights from the ACCORD trial
Sign Up to like & getrecommendations! Published in 2022 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.3602
Abstract: Visceral adiposity index (VAI) was a reliable marker for visceral adiposity accumulation and dysfunction. The association between VAI and nephropathy outcomes remains uncertain in patients with type 2 diabetes (T2DM). We aimed to evaluate the… read more here.
Keywords: adiposity index; incident nephropathy; visceral adiposity; nephropathy outcomes ... See more keywords